Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBNY
3201
PUT
DELISTED
Signature Bank
SBNY
| $3.68M | ﹤0.01% |
13,500
+10,500
| +350% | +$2.64M |
|
|
IIN
3202
DELISTED
IntriCon Corporation
IIN
| $3.66M | ﹤0.01% |
201,769
-41,695
| -17% | -$899K |
|
3203
PUT
Phillips 66
PSX
$84.9B
| $3.66M | ﹤0.01% |
52,300
+4,500
| +9% | +$326K |
|
|
AGTC
3204
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.66M | ﹤0.01% |
1,216,917
-534,401
| -31% | -$1.9M |
|
3205
Blue Owl Capital
OBDC
$5.34B
| $3.66M | ﹤0.01% |
259,378
+69,976
| +37% | +$1.01M |
|
|
TGP
3206
DELISTED
Teekay LNG Partners L.P.
TGP
| $3.66M | ﹤0.01% |
+235,429
| New | +$3.48M |
|
3207
CEVA Inc
CEVA
$910M
| $3.65M | ﹤0.01% |
85,661
+59,449
| +227% | +$2.7M |
|
|
ITMR
3208
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $3.65M | ﹤0.01% |
120,895
-265,717
| -69% | -$5.88M |
|
3209
Groupon
GRPN
$1.05B
| $3.65M | ﹤0.01% |
160,079
+72,737
| +83% | +$2.15M |
|
3210
Nabors Industries
NBR
$1.27B
| $3.65M | ﹤0.01% |
37,824
-3,241
| -8% | -$282K |
|
|
BSAQ.U
3211
DELISTED
Black Spade Acquisition Co Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
BSAQ.U
| $3.65M | ﹤0.01% |
+367,700
| New | +$3.66M |
|
3212
CALL
Rockwell Automation
ROK
$53.4B
| $3.65M | ﹤0.01% |
+12,400
| New | +$3.81M |
|
3213
Winnebago Industries
WGO
$856M
| $3.64M | ﹤0.01% |
50,237
+45,400
| +939% | +$3.17M |
|
|
OEPWU
3214
DELISTED
One Equity Partners Open Water I Corp. Unit
OEPWU
| $3.62M | ﹤0.01% |
365,002
-7,469
| -2% | -$74.2K |
|
3215
American Superconductor
AMSC
$1.42B
| $3.62M | ﹤0.01% |
248,184
+79,405
| +47% | +$1.1M |
|
3216
Onto Innovation
ONTO
$12.9B
| $3.62M | ﹤0.01% |
50,029
+22,594
| +82% | +$1.63M |
|
3217
Xenon Pharmaceuticals
XENE
$6.06B
| $3.61M | ﹤0.01% |
236,219
-65,529
| -22% | -$1.14M |
|
|
DHC
3218
Diversified Healthcare Trust
DHC
$2.15B
| $3.6M | ﹤0.01% |
1,062,575
-143,198
| -12% | -$540K |
|
3219
AnaptysBio
ANAB
$1.58B
| $3.6M | ﹤0.01% |
132,709
+25,189
| +23% | +$639K |
|
3220
CALL
Danaher
DHR
$137B
| $3.59M | ﹤0.01% |
13,310
-69,034
| -84% | -$18.8M |
|
|
ESM
3221
DELISTED
ESM Acquisition Corporation
ESM
| $3.59M | ﹤0.01% |
367,956
+135,120
| +58% | +$1.31M |
|
3222
CALL
Stryker
SYK
$125B
| $3.59M | ﹤0.01% |
13,600
-161,200
| -92% | -$43.1M |
|
3223
CALL
Cigna
CI
$73.7B
| $3.58M | ﹤0.01% |
17,900
+12,700
| +244% | +$2.76M |
|
3224
Monarch Casino & Resort
MCRI
$2.2B
| $3.58M | ﹤0.01% |
53,435
-2,997
| -5% | -$194K |
|
|
MDC
3225
DELISTED
M.D.C. Holdings, Inc.
MDC
| $3.58M | ﹤0.01% |
76,574
-249,658
| -77% | -$12.6M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.